Recent Finacing
Recent Raise
Algiax Pharmaceuticals is a clinical-stage biotech developing peripherally restricted GABAA receptor modulators, including lead AP-325 for neuropathic pain (Phase IIa planned), plus Thioacrylamide derivatives in preclinical development.
